H.R. 4151 · 108th Congress
Brian Lykins Human Tissue Transplant Safety Act of 2004
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
KlineSponsor18 cosponsors · 6 D, 12 R
R
Beauprez
GG
R
Gutknecht
JH
R
Hefley
MK
R
Kennedy
SM
R
McInnis
BM
D
McCollum
MM
R
Musgrave
JO
D
Oberstar
CP
D
Peterson
JR
R
Ramstad
MS
D
Sabo
BG
D
Gordon
CN
R
Norwood
DB
R
Burton
MB
R
Burgess
TF
R
Franks
JP
R
Pitts
ET
D
Towns11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Brian Lykins Human Tissue Transplant Safety Act of 2004 - Amends the Public Health Service Act to provide for oversight by the Commissioner of Food and Drugs of entities engaged in activities relating to human tissue or human tissue-based products, requiring their registration and authorizing their inspection.
What it does: CRS summary · Introduced in House · Apr 2, 2004
Brian Lykins Human Tissue Transplant Safety Act of 2004 - Amends the Public Health Service Act to provide for oversight by the Commissioner of Food and Drugs of entities engaged in activities relating to human tissue or human tissue-based products, requiring their registration and authorizing their inspection. Requires the reporting of any adverse incidents. Requires the Commissioner to develop a reporting mechanism and a database to store such information.
Allows the Commissioner, in an instance in which this Act is violated, to: (1) issue an order requiring any distributor of a human cell, tissue, or cellular or tissue-based product to recall or destroy such product; (2) condemn, seize, and destroy such product; (3) require a covered entity to cease the activity that resulted in the violation; or (4) suspend or revoke the registration and listing of the covered entity involved.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Brian Lykins Human Tissue Transplant Safety Act of 2004
Latest action (Apr 8, 2004): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 2, 2004
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.